Table 6.
Laboratory evaluation before and after exchange transfusion (ET).
| Laboratory Data | Pre-ET (n = 50) | Post-ET (n = 51) | p Value * |
|---|---|---|---|
| Complete Blood Cell Count | |||
| White cell blood count, cells/mm3, median (IQR) | 4750 (2890–11,530) | 10,630 (6152–16,290) | 0.02 |
| Neutrophils, cells/mm3, median (IQR) | 1690 (980–5095) | 5130 (3245–8665) | 0.08 |
| Platelets, n/mm3, median (IQR) | 87,500 (38,700–155,500) | 37,500 (14,500–61,200) | <0.001 |
| C-reactive Protein, mg/dL, Median (IQR) | 4.71 (0.9–10.13) | 5.52 (1.04–12.03) | 0.18 |
| Blood Gas Analysis | |||
| Base excess, mmol/L, median (IQR) | −8.8 (−13.1, −5.7) | −5.2 (−8.5, −3.2) | <0.001 |
| Serum lactate, mmol/L, median (IQR) | 6.95 (3–12.4) | 5.6 (2.6–12.6) | 0.88 |
| Kidney Assessment | |||
| Serum creatinine, U/L, median (IQR) | 0.75 (0.6–1.02) | 0.95 (0.6–1.22) | 0.22 |
| Serum urea, U/L, median (IQR) | 49 (35.5–64.5) | 78 (43–101) | 0.0002 |
* Wilcoxon signed-ranks test for quantitative variables, Stuart–Maxwell test for categorical variables; ET: Exchange transfusion; ScT: Standard care therapy; IQR: Interquartile range. Bold number: p Value ≤ 0.05.